Skip to main content
Erschienen in: BMC Pulmonary Medicine 1/2021

Open Access 01.12.2021 | Research article

Heart rate recovery in asthmatic children and adolescents after clinical field test

verfasst von: Élida Pereira Silva, Bruno Alvarenga Soares, Mariana M. Reimberg, Raphael Ritti-Dias, Karina Silva Nascimento, Fabiana Silvia Anjos, Gustavo Falbo Wandalsen, Dirceu Solé, Simone Dal Corso, Fernanda Cordoba Lanza

Erschienen in: BMC Pulmonary Medicine | Ausgabe 1/2021

Abstract

Background

Inflammation caused by chronic lung disease in childhood may lead to delayed heart rate recovery (HRR) however, there is lack of evidence on HRR in this population. The aim was to assess HRR after functional capacity testing in asthmatic children and adolescents and to compare with severity and disease control.

Method

This was a study secondary to a randomized control trial. The modified shuttle test (MST) was performed to assess functional capacity and HRR. This is an externally cadenced test in which the distance walked is the outcome. HRR was assessed after MST and was defined as HR at exercise peak minus HR in the second minute after the end of exercise. Asthma control was assessed by the Asthma Control Test (ACT). Data normality was tested by Shapiro Wilk and the comparison between groups was made by Student’s t test or Mann Whitney test for numerical variables, and by Chi-square test for categorical variables. Statistical significance was considered when p < 0.05. SPSS version 20 was used in the analyzes.

Results

The sample included 77 patients diagnosed with asthma (asthma group - AG) who were regularly treated for asthma. Control group (CG) consisted of 44 volunteers considered healthy, matched in age and gender to AG. The median age of CG was 12 (10–14) years and in AG 11 (9–13 years) being classified as mild to moderate asthmatic, and 57% of the sample had controlled asthma by ACT. Distance walked in the CG was 952 ± 286 m and AG 799 ± 313 m, p = 0.001. HRR was more efficient in CG (79 ± 15 bpm) compared to AG (69 ± 12 bpm), p = 0.001. The mild (69 ± 12 beats) and severe (72 ± 15 beats) AG presented worse HRR compared to control group (79 ± 15 bpm), p < 0.05.

Conclusions

Asthmatic children and adolescents have delayed HRR after modified Shuttle test compared to their peers, suggesting that asthma leads to autonomic nervous system imbalance.
Trial registration: Registered in Clinical Trials under number NCT02383069 and approved by the Universidade Nove de Julho - UNINOVE Research Ethics Committee, protocol number 738192/2014.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
%pred
Predicted percentage
μg
Microgram
ACT
Asthma Control Test
AG
Asthma group
ATS
American Thoracic Society
BMI
body mass index
Bpm
Beats per minute
C-ACT
Childhood Asthma Control Test
CG
Control group
CPET
Cardiopulmonary exercise testing
ERS
European Respiratory Society
FEF25–75
Forced expiratory flow between 25 and 75% of FVC
FEV1
Forced expiratory volume in one second
FVC
Forced vital capacity
GINA
Global Initiative for Asthma
HR
Heart rate
HRR
Heart rate recovery
HRV
Heart rate variability
kg/m2
Kilogram per square meter
LF/HF
Low frequency and hight frequency ratio
MST
Modified shuttle test
SABA
Short-acting Beta2 agonist
ΔHRR
Heart rate recovery delta

Background

Heart rate recovery (HRR) is defined as the reduction in heart rate to baseline after a period of stress [1]. It reflects the balance of the autonomic nervous system, since the reduction in heart rate after exercise is related to the interaction of parasympathetic and sympathetic activity [1, 2]. Initially, the sudden fall in heart rate occurs through parasympathetic reactivation and the sympathetic system withdrawal reduces even further these values [1, 2].
Lower values of HRR after maximum [2] and submaximum exercise [3] reflect an autonomic nervous system imbalance [2]. This situation is associated with increased risk of cardiovascular and cardiometabolic events [4], and also mortality in chronic diseases [2].
In healthy children and adolescents, HRR was assessed after cardiopulmonary exercise testing (CPET) [5] and after clinical field tests, such as the 6-min walk test [6] and the 3-min step test [7]. The association of HRR with cardiometabolic risk has already been described in children [7] as well as in adults [4].
Sympathovagal imbalance was observed in individuals with asthma, however this dysfunction was assessed by the analysis of heart rate variability (HRV) [8, 9]. Both HRR and HRV methods are related to the autonomic nervous system [10]. However, HRV may be influenced by environmental factors (noise, light, temperature, etc.), while HRR is a simpler method, and is calculated in absolute heart rate values and no specific software is required for its use [1, 2]. To the best of our knowledge, no study has evaluated autonomic dysfunction through HRR in asthmatic children.
Asthma patients are known to have reduced functional capacity assessed by simple tests such as the Shuttle test [11]. Modified Shuttle test (MST) is an externally cadenced field test with maximum test characteristics [11, 12]. Because it is easy to perform and provides useful information on exercise capacity [12], MST is a promising test to evaluate HRR in asthmatic children.
Since asthma is a chronic inflammatory disease associated with the patient’s sedentary lifestyle [11], it is hypothesized that there is sympathovagal dysfunction and that it can be detected by HRR after a clinical field test. Thus, this study aims to evaluate HRR after functional capacity testing in asthmatic children and adolescents to compare with severity and disease control.

Method

This was a study secondary to the a randomized clinical trial registered in Clinical Trials under number ClinicalTrials.gov Identifier: NCT02383069 and approved by the Universidade Nove de Julho - UNINOVE Research Ethics Committee, protocol number 738192/2014. The study was performed at the Rehabilitation Laboratory at Universidade Nove de Julho. Patients were from the Asthma Clinic of the Discipline of Allergy, Clinical Immunology and Rheumatology of the Department of Pediatrics of UNIFESP. After signing the Informed Consent Form by the parents / guardians and signing the Child / Adolescent Consent Form, the assessments were initiated.
The study consisted of two groups: asthma group (AG) and control group (CG). Children and adolescents from 6 to 17 years of age, of both sexes, under regular asthma treatment for at least 3 months and with adherence to medical treatment, based on physician appointment, with specialist follow-up, all the severities of GINA Steps [13] with no exacerbation in the last 4 weeks were included in the AG. In the CG, healthy volunteers without acute illnesses in the last 4 weeks were included, normal lung function (> 80% of normal value) [14] matched by age and sex to AG in a 2:1 ratio. Those born prematurely and unable to perform the proposed tests were excluded.
To evaluate the asthma severity, AG were split according to GINA as mild asthma (GINA Steps 1 and 2), moderate asthma (GINA Step 3) and severe asthma (GINA Steps 4 and 5), and compared to the control group. To evaluate the asthma control, the volunteers were split into controlled asthma (ACT / C-ACT > 19), and poor or uncontrolled asthma (ACT / C-ACT ≤19), and compared to the control group.

Protocol

The evaluations took place between April 2014 and November 2015 in a single visit. The following procedures were performed: application of the asthma control questionnaire (ACT or C-ACT, spirometry (pre and post bronchodilator) and the modified Shuttle test (MST).

Ashma assessment

The ACT - Asthma Control Test [15] and C-ACT - Child Asthma Control Test [16] questionnaires are questionnaires for assessing asthma control based on patient perception. It refers to activity limitation, dyspnea and nocturnal symptoms in the last 4 weeks. Answers are scored from one (worst) to five (best), with the highest score indicating better asthma control. The ACT questionnaire consists of five questions and the C-ACT, applied to children aged 4–11 years, consists of seven questions, four directed to children and three to caregivers. In both questionnaires, asthma was considered controlled when the score was greater than 19, and uncontrolled when the score was ≤19 [16].

Lung function

Spirometry was performed using the equipment Ultima CPX (MedGraphics Corporation®, St. Paul, MN, USA). Acceptability and reproducibility criteria were in accordance with ATS / ERS recommendations [17]. The variables analyzed were forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), FEV1 / FVC ratio and forced expiratory flow between 25 and 75% of FVC (FEF25–75). AG volunteers performed a pre and post bronchodilator test (Salbutamol 400 μg – inhaled drug).
Anthropometric variables (weight and height) were evaluated to characterize the sample and to determine the lung function normality. Additionally, the body mass index (BMI) was used and eutrophic cut off based on Z-score [18].

Modified shuttle test (MST)

MST was performed according to ERS / ATS recommendations [19]. This is an externally cadenced test in which the test speed increases each minute, from 1.79 to 10.2Km/h. It is performed in a 10 m corridor and volunteers are allowed to walk/run. The test was performed twice with an interval of 30 min between them. HR and SpO2 were measured at rest (before the start of the test), continuously during the MST, and after 2 min of the end of the test. The distance walked from the best test was used as an outcome and was represented in absolute values and as a percentage of predicted [20]. In AG, MST was performed at least 30 min after Salbutamol administration.
Heart rate was measured by the POLAR® Ft2 heart rate monitor positioned at the height of the sternum xiphoid process. The HRR was calculated as the HR peak (at the end of MST) minus the HR recovery (at the second minute after MST), (HRR = HR peak – HR recovery) as described in previous studies [15, 21, 22].

Statistical analysis

Data normality was tested by Shapiro Wilk and presented as mean (standard deviation) or median (interquartile range 25–75) according to adherence to the Gauss curve.
The comparison between groups was made by Student’s t test or Mann Whitney test for numerical variables, and by Chi-square test for categorical variables.
To evaluate the asthma severity, AG were split according to GINA as mild asthma (GINA Steps 1 and 2 – n = 25), moderate asthma (GINA Step 3 – n = 30) and severe asthma (GINA Steps 4 and 5 – n = 22), and compared to the control group (n = 44). To evaluate the asthma control, the volunteers were split into controlled asthma (ACT / C-ACT > 19), and poor or uncontrolled asthma (ACT / C-ACT ≤19), and compared to the control group. These comparisons were made by one-way ANOVA or Kruskal Wallis according to normality.
Statistical significance was considered when p < 0.05. SPSS version 20 was used in the analyzes.

Results

Eighty-four AG volunteers were recruited, seven of whom were excluded because they had no interest in participating or for other associated diseases, of which 77 were included. In the CG 48 were eligible, 4 excluded because they could not perform the tests and because of spirometry abnormalities; thus, 44 volunteers participated in the CG. The median age in AG was 11 (9–13 years), 78% of volunteers were eutrophic and 64% male, with normal lung function. Regarding the severity of the disease, n = 25 (32%) were GINA Steps 1 and 2; n = 30 (39%) were GINA Step 3 ; and n = 22 (29%) were GINA Steps 4 and 5. According to asthma control, 57% (44) of the sample had controlled asthma. Anthropometric characteristics and lung function are described in Table 1.
Table 1
Anthropometric and lung function for asthma and control groups
 
AG (n = 77)
CG (n = 44)
p
Age, years
11 [9–13]
12 [10–14]
0.14
Children, n (%)
40 (52)
19 (43)
0.35
Gender (male), n (%)
49 (64)
24 (55)
0.32
BMI, Kg/m2
19 [16–23]
19 [17–24]
0.76
Eutrofic Z-score, n (%)
60 (78)
37 (84)
0.51
FVC, L (%pred)
2.6 [2.1–3.1] (103 [94–109])
2.8 [2.2–3.4] (109 [97–122])
0.23
FEV1, L (%pred)
2.3 [1.8–2.9] (96 [85–106])
2.4 [1.8–3.0] (102 [88–114])
0.28
FEV1/FVC
88 [82–92]
87 [80–92]
0.40
FEF 25–75%, L (%pred)
2.3 [1.8–3.2] (95 [71–116])
2.9 [2.1–3.8] (96 [82–127])
0.03
BMI body mass index, kg/m2 kilogram per square meter, FVC forced vital capacity, %pred percentage predicted for age and gender, VEF1 forced expiratory volume in the first second, FEV1/FVC ratio of forced expiratory volume in the first second divided by forced vital capacity, FEF25-75% forced expiratory flow 25 to 75%
About functional capacity, the AG had shorter distance walked in the MST compared to the CG, p = 0.001 (Table 2). At rest, HR was statically higher in AG (93 ± 13 bpm) compared to CG (86 ± 13 bpm), p = 0.003, although at exercise peak there was no statistically significant different between groups, p = 0.06 (Table 2). HRR was worse in AG, with lower HR decrease after exercise (79 ± 15 bpm) compared to CG (69 ± 12 bpm), p = 0.001.
Table 2
Heart rate behavior and distance walked in the Shuttle Modified Test between groups
 
AG (n = 77)
CG (n = 44)
p
Distance walked, meters (%pred)
799 ± 213 (83 ± 18)
952 ± 286 (95 ± 19)
0.001
Heart rate at rest, bpm
93 ± 13
86 ± 13
0.003
Heart rate at peak, bpm
187 [179–196]
192 [184–200]
0.06
Heart rate 2°min recovery, bpm
116 ± 16
112 ± 18
0.13
ΔHRR, beats
69 ± 12
79 ± 15
0.001
ΔHRR heart rate recovery delta (Heart rate at peak – heart rate at 2°minute recovery)
The AG was split into subgroups according to severity and compared to CG. Only the severe and mild asthma groups had lower ΔHRR compared to the CG (severe x control, p = 0.014 and mild x control, p = 0.013). (Fig. 1).
Asthma control assessed by ACT and C-ACT influenced the ΔHRR. The control group showed better heart rate recovery when compared to controlled asthma group (> 19) and with partially or uncontrolled asthma group (≤19), p = 0.02. However, there was no difference between under control asthma group and partially or uncontrolled asthma group (p = 0.56) (Fig. 2).
In AG, the ΔHRR did not correlate significantly with distance walked (r = 0.09, p = 0.39), asthma severity (r = − 0.07, p = 0.53) and asthma control (r = 0.17, p = 0.11). Similarly, in the CG, distance walked had no statistically significant correlation with ΔHRR (r = 0.12, p = 0.40).
Considering a one-tailed curve, because the hypothesis was that asthma group had worse HRR, with p 0.05, N = 77 for asthma group and N = 44 for control group, the post hoc power was 83%. According to the asthma severity: mild (n = 25), moderate (n = 30), severe (n = 22) compared to the control group (n = 44), the post hoc power was 99%, with p = 0.05. According to the asthma control, controlled asthma (n = 33) poor or uncontrolled asthma (n = 44) compared to the control group (n = 44), the post hoc power was 98%, with p = 0 .05.

Discussion

After assessed asthmatic children and adolescents, it was observed that HRR after modified shuttle test is worse when compared to healthy peers. Additionally, the severity of the disease impairs the recovery of heart rate. The HR recovery delay after exercise may be indicative of autonomic dysfunction caused by sympathovagal imbalance [24]. This is the first study to assess HRR autonomic dysfunction in asthmatic children and adolescents.
The severity of asthma (severe and mild) was related to worse HRR compared to the CG. Although there was no statistically difference of HRR in the moderate asthma group compared to CG, it is known that this difference is clinically important. Qiu et al. [4] describe in their meta-analysis that every 10 beats per minute reduced in heart rate recovery increases the risk of cardiovascular events by 13% and the risk of mortality by 9% compared to general population. Emin et al. [23] also assessed autonomic dysfunction in 77 asthmatic children, divided by the severity of the disease into mild, moderate and severe, through HRV. There was positive correlation between asthma severity and autonomic modulation, in other words, the higher parasympathetic dysfunction is related to disease severity. In our study, this parasympathetic dysfunction was demonstrated by the recovery of the most slowed HR in AG (severe and mild) compared to the control group.
Some studies reported the correlation between HRV and severity of the disease. Milagro et al. [8] analyzed HRV in preschoolers divided into 3 groups based on the risk of developing asthma (high and low risk) and the group treated with inhaled corticosteroids (confirmed asthma). This study also observed reduction in sympathovagal balance in the high-risk group, with results similar to the confirmed asthma group. This shows an intrinsic change in autonomic nervous system in disease groups. Gomes et al. [9] suggest a predominance of sympathetic activity during crisis, which could be explained by the greater release of inflammatory mediators during this period. In controlled asthmatics, they observed higher parasympathetic activity. In the present study, the recovery of heart rate suggests an increased sympathetic activity, even in volunteers out of the crisis period and in undergoing treatment.
Additionally, a variable described as a predictor of HRR is resting heart rate [5]. AG volunteers had higher resting HR compared to CG and slower HRR with statistically significant difference. This finding corroborates other previous studies [5, 7, 24, 25] that also observed slower HRR in volunteers with higher resting HR. Some hypotheses may explain this fact, such as the sedentary lifestyle [11] imposed by the disease, use of chronic medications and inhalation of salbutamol (400 μg) before the test, and also the inflammatory profile in chronic disease. Previous study in asthmatic children showed that medication increases heart rate by 13% and this effect lasts for 45 min [26].
According to disease control, our study observed no difference in HRR when compared to controlled and partially controlled asthmatics, different from Lufti’s study [27] in which controlled asthmatic adults demonstrated higher parasympathetic activation (higher HF component and lower LF / HF ratio) compared to uncontrolled asthma group, however, in a different population from our study.
Clinical field tests may be an easy alternative to CPET. There is positive association between HRR at step test and oxygen consumption evaluated in CPET [28]. Our study presents the possibility of evaluating HRR during MST, an easy to perform low cost test with a maximum assessment  [12, 20].
Although no study in children has defined abnormal values for HRR as already has been described for adults [2, 3], studies have shown that HRR delay can predict cardiovascular risk [5, 7], metabolic risk [5, 6, 29] and worse exercise capacity [5]. Also, HRR may be modifiable with participation in regular physical activity [5].
Some limitations are presented in this study. As this was a study secondary to an RCT, the physical activity level of this sample was not evaluated, which could be analyzed as a possible predictor of HRR. Only two studies evaluated physical activity level and observed better HRV in more active children [7, 29]. Another limitation was the non-evaluation of HR before short agonist bronchodilator (SABA) to determine if there was any influence of medication on resting HR before MST. However, the test was performed at least 30 min after bronchodilator use, which minimizes the effects of the short-acting medication. Additionally, for safety reasons, we could not perform an expected maximal exercise test without SABA, due to the induced bronchospasm exercise risk in asthmatic volunteers.

Conclusions

In conclusion, children and adolescents with asthma who are under regular treatment have worse HRR after exercise compared to their healthy peers. This information is suggestive of imbalance of autonomic nervous system.

Acknowledgements

Not applicable.
This cross-sectional study is secondary to the randomized clinical trial registered in Clinical Trials under number NTC02383069 and was approved by the ethics and research committee of Universidade Nove de Julho under number 738192/2014. Participants were enrolled in the study after their legal guardians had read, agreed to, and signed the informed consent form. After that, the participant read, agreed to, and signed the informed assent form.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Shelter K, Marcus R, Froelicher VF, Vora S, Kalisetti, Prakashi M, Do D, Myers J. Heart rate recovery: validation and Methodologic issues. J Am Coll Cardiol. 2001;38:1980–7.CrossRef Shelter K, Marcus R, Froelicher VF, Vora S, Kalisetti, Prakashi M, Do D, Myers J. Heart rate recovery: validation and Methodologic issues. J Am Coll Cardiol. 2001;38:1980–7.CrossRef
2.
Zurück zum Zitat Cole CR, Blackstone EH, Pashkow FJ, Snader CE, Lauer MS. Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med. 1999;341:1351–7.CrossRef Cole CR, Blackstone EH, Pashkow FJ, Snader CE, Lauer MS. Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med. 1999;341:1351–7.CrossRef
3.
Zurück zum Zitat Cole CR, Foody JM, Blackstone EH, Lauer MS. Heart rate recovery after submaximal exercise testing as a predictor of mortality in a cardiovasculary healthy cohort. Ann Intern Med. 2000;132(7):552–5.CrossRef Cole CR, Foody JM, Blackstone EH, Lauer MS. Heart rate recovery after submaximal exercise testing as a predictor of mortality in a cardiovasculary healthy cohort. Ann Intern Med. 2000;132(7):552–5.CrossRef
5.
Zurück zum Zitat Singh TP, Rhodes J, Gauvreau K. Determinants of heart rate recovery following exercise in children. Med Sci Sports Exerc. 2008;40:601–5.CrossRef Singh TP, Rhodes J, Gauvreau K. Determinants of heart rate recovery following exercise in children. Med Sci Sports Exerc. 2008;40:601–5.CrossRef
6.
Zurück zum Zitat Tellez MJA, Soto-Sánchez J, Weisstaub SG. Physical fitness, cardiometabolic risk and heart rate recovery in Chilean children. Nutr Hosp. 2018;35(1):44–9. Tellez MJA, Soto-Sánchez J, Weisstaub SG. Physical fitness, cardiometabolic risk and heart rate recovery in Chilean children. Nutr Hosp. 2018;35(1):44–9.
7.
Zurück zum Zitat Simhaee D, Corriveau N, Gurm R, Geiger Z, Kline-Rogers E, Goldberg C, et al. Recovery heart rate: an indicator of cardiovascular risk among middle school children. Pediatr Cardiol. 2013;34(6):1431–7.CrossRef Simhaee D, Corriveau N, Gurm R, Geiger Z, Kline-Rogers E, Goldberg C, et al. Recovery heart rate: an indicator of cardiovascular risk among middle school children. Pediatr Cardiol. 2013;34(6):1431–7.CrossRef
8.
Zurück zum Zitat Milagro J et al. Nocturnal heart rate variability Spectrum characterization in preschool children with asthmatic symptoms. J Biomed Health Informatics 2018 22(05). Milagro J et al. Nocturnal heart rate variability Spectrum characterization in preschool children with asthmatic symptoms. J Biomed Health Informatics 2018 22(05).
14.
Zurück zum Zitat Polgar G, Promadhat V. Pulmonary function testing in children: techniques and standards. Philadelphia: Saunders; 1971. Polgar G, Promadhat V. Pulmonary function testing in children: techniques and standards. Philadelphia: Saunders; 1971.
15.
Zurück zum Zitat Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59–65.CrossRef Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59–65.CrossRef
16.
Zurück zum Zitat Liu AH, Zeiger RS, Sorkness CA, Mahr T, Ostrom N, Burguess S, et al. Development and cross-sectional validation of the childhood asthma control test. J Allergy Clin Immunol. 2007;119:817–25.CrossRef Liu AH, Zeiger RS, Sorkness CA, Mahr T, Ostrom N, Burguess S, et al. Development and cross-sectional validation of the childhood asthma control test. J Allergy Clin Immunol. 2007;119:817–25.CrossRef
17.
Zurück zum Zitat American Thoracic Society (ATS). European Respiratory Society (ERS). Skeletal muscle dysfunction in chronic obstrutive pulmonar disease. A statament of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med. 1999;159:S1–40. American Thoracic Society (ATS). European Respiratory Society (ERS). Skeletal muscle dysfunction in chronic obstrutive pulmonar disease. A statament of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med. 1999;159:S1–40.
18.
Zurück zum Zitat Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Orientações para a coleta e análise de dados antropométricos em serviços de saúde: Norma Técnica do Sistema de Vigilância Alimentar e Nutricional – SISVAN. Brasília: Ministério da Saúde, 2011. Acesso: http://bvsms.saude.gov.br/bvs. Accessed 26 Feb 2020. Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Orientações para a coleta e análise de dados antropométricos em serviços de saúde: Norma Técnica do Sistema de Vigilância Alimentar e Nutricional – SISVAN. Brasília: Ministério da Saúde, 2011. Acesso: http://​bvsms.​saude.​gov.​br/​bvs. Accessed 26 Feb 2020.
19.
Zurück zum Zitat Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428–46.CrossRef Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428–46.CrossRef
20.
Zurück zum Zitat Lanza FC, Zagatto EP, Silva JC, Imperatori TB, Zanatta TJ, Carvalho LN, et al. Reference equation for the incremental shuttle walk test in children and adolescents. J Pediatr. 2015;167:1057–61.CrossRef Lanza FC, Zagatto EP, Silva JC, Imperatori TB, Zanatta TJ, Carvalho LN, et al. Reference equation for the incremental shuttle walk test in children and adolescents. J Pediatr. 2015;167:1057–61.CrossRef
21.
Zurück zum Zitat Lipinski MJ, Vetrovec GW, Froelicher VF. Importance of the first two minutes of heart rate recovery after exercise treadmill testing in predicting mortality and the presence of coronary artery disease in men. Am J Cardiol. 2004;93(4):445–9.CrossRef Lipinski MJ, Vetrovec GW, Froelicher VF. Importance of the first two minutes of heart rate recovery after exercise treadmill testing in predicting mortality and the presence of coronary artery disease in men. Am J Cardiol. 2004;93(4):445–9.CrossRef
22.
Zurück zum Zitat Peçanha T, Silva-Júnior ND, Forjaz CLM. Heart rate recovery: autonomic determinants, methods of assessment and association with mortality and cardiovascular diseases. Clin Physiol Funct Imaging. 2014;34(5):327–39.CrossRef Peçanha T, Silva-Júnior ND, Forjaz CLM. Heart rate recovery: autonomic determinants, methods of assessment and association with mortality and cardiovascular diseases. Clin Physiol Funct Imaging. 2014;34(5):327–39.CrossRef
23.
Zurück zum Zitat Emin O, Esra G, Aysegül D, Ufuk E, et al. Autonomic nervous system dysfunction and their relationship with disease severity in children with atopic asthma. Respir Physiol Neurobiol. 2012;183:206–10.CrossRef Emin O, Esra G, Aysegül D, Ufuk E, et al. Autonomic nervous system dysfunction and their relationship with disease severity in children with atopic asthma. Respir Physiol Neurobiol. 2012;183:206–10.CrossRef
24.
Zurück zum Zitat Alvarado AM, Ward KM, Muntz DS, Thompson AA, Rodeghier M, Fernhall B, Liem RI. Heart rate recovery is impaired after maximal exercise testing in children with sickle cell anemia. J Pediatr. 2015;166:389–93.CrossRef Alvarado AM, Ward KM, Muntz DS, Thompson AA, Rodeghier M, Fernhall B, Liem RI. Heart rate recovery is impaired after maximal exercise testing in children with sickle cell anemia. J Pediatr. 2015;166:389–93.CrossRef
25.
Zurück zum Zitat Mahon AD, Anderson CS, Hipp MJ, Hunt KA. Heart rate recovery from submaximal exercise in boys and girls. Med Sci Sports Exerc. 2003;35(12):2093–7 9.CrossRef Mahon AD, Anderson CS, Hipp MJ, Hunt KA. Heart rate recovery from submaximal exercise in boys and girls. Med Sci Sports Exerc. 2003;35(12):2093–7 9.CrossRef
26.
Zurück zum Zitat Milner AD, Igram D. Bronchodilator and cardiac effects of Isoprenaline, Orciprenaline, and salbutamol aerosols in asthma. Arch Dis Child. 1971;46:502.CrossRef Milner AD, Igram D. Bronchodilator and cardiac effects of Isoprenaline, Orciprenaline, and salbutamol aerosols in asthma. Arch Dis Child. 1971;46:502.CrossRef
28.
Zurück zum Zitat Cohen SP, Orenstein DM. How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF? J Cyst Fibros. 2014;13:712–5.CrossRef Cohen SP, Orenstein DM. How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF? J Cyst Fibros. 2014;13:712–5.CrossRef
29.
Zurück zum Zitat Laguna M, Aznar S, Lara MT, Lucia A, Ruiz JR. Heart rate recovery is associated with obesity traits and related cardiometabolic risk factors in children and adolescents. Nutr Metab Cardiovasc Dis. 2013;23(10):995–1001.CrossRef Laguna M, Aznar S, Lara MT, Lucia A, Ruiz JR. Heart rate recovery is associated with obesity traits and related cardiometabolic risk factors in children and adolescents. Nutr Metab Cardiovasc Dis. 2013;23(10):995–1001.CrossRef
Metadaten
Titel
Heart rate recovery in asthmatic children and adolescents after clinical field test
verfasst von
Élida Pereira Silva
Bruno Alvarenga Soares
Mariana M. Reimberg
Raphael Ritti-Dias
Karina Silva Nascimento
Fabiana Silvia Anjos
Gustavo Falbo Wandalsen
Dirceu Solé
Simone Dal Corso
Fernanda Cordoba Lanza
Publikationsdatum
01.12.2021
Verlag
BioMed Central
Erschienen in
BMC Pulmonary Medicine / Ausgabe 1/2021
Elektronische ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-020-01355-9

Weitere Artikel der Ausgabe 1/2021

BMC Pulmonary Medicine 1/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.